Page last updated: 2024-10-21

3-methoxytyramine and Psychoses, Drug

3-methoxytyramine has been researched along with Psychoses, Drug in 3 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yui, K3
Goto, K3
Ikemoto, S3
Ishiguro, T2
Kamata, Y1
Nishijima, K1
Yoshino, T1

Trials

1 trial available for 3-methoxytyramine and Psychoses, Drug

ArticleYear
Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
    European archives of psychiatry and clinical neuroscience, 1999, Volume: 249, Issue:2

    Topics: Adaptation, Psychological; Adult; Analysis of Variance; Dopamine; Female; Humans; Methamphetamine; N

1999

Other Studies

2 other studies available for 3-methoxytyramine and Psychoses, Drug

ArticleYear
The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence.
    Annals of the New York Academy of Sciences, 2004, Volume: 1025

    Topics: Adult; Analysis of Variance; Chi-Square Distribution; Disease Susceptibility; Dopamine; Female; Huma

2004
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
    Drug and alcohol dependence, 2001, Oct-01, Volume: 64, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Arousal; Dopamine; Female; Humans; Life Change Events; Metham

2001